- Home
- KYMR vs SPNT Comparison
KYMR vs SPNT Comparison
Compare KYMR & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- SPNT
- Stock Information
- Founded
- KYMR 2015
- SPNT 2011
- Country
- KYMR United States
- SPNT Bermuda
- Employees
- KYMR N/A
- SPNT N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- SPNT Property-Casualty Insurers
- Sector
- KYMR Health Care
- SPNT Finance
- Exchange
- KYMR Nasdaq
- SPNT Nasdaq
- Market Cap
- KYMR 2.1B
- SPNT 2.3B
- IPO Year
- KYMR 2020
- SPNT N/A
- Fundamental
- Price
- KYMR $33.45
- SPNT $14.48
- Analyst Decision
- KYMR Buy
- SPNT
- Analyst Count
- KYMR 13
- SPNT 0
- Target Price
- KYMR $56.69
- SPNT N/A
- AVG Volume (30 Days)
- KYMR 695.8K
- SPNT 863.1K
- Earning Date
- KYMR 05-01-2025
- SPNT 04-29-2025
- Dividend Yield
- KYMR N/A
- SPNT N/A
- EPS Growth
- KYMR N/A
- SPNT N/A
- EPS
- KYMR N/A
- SPNT 1.04
- Revenue
- KYMR $47,072,000.00
- SPNT $2,656,400,000.00
- Revenue This Year
- KYMR $44.93
- SPNT N/A
- Revenue Next Year
- KYMR N/A
- SPNT N/A
- P/E Ratio
- KYMR N/A
- SPNT $13.86
- Revenue Growth
- KYMR N/A
- SPNT N/A
- 52 Week Low
- KYMR $29.07
- SPNT $11.49
- 52 Week High
- KYMR $53.27
- SPNT $16.50
- Technical
- Relative Strength Index (RSI)
- KYMR 44.68
- SPNT 48.36
- Support Level
- KYMR $31.54
- SPNT $14.34
- Resistance Level
- KYMR $31.66
- SPNT $15.05
- Average True Range (ATR)
- KYMR 2.31
- SPNT 0.48
- MACD
- KYMR 0.37
- SPNT -0.02
- Stochastic Oscillator
- KYMR 51.20
- SPNT 30.07
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.